The Platform Group AG Expands Ownership in ApoNow, Strengthening Market Position

The Platform Group AG, a notable entity in the software solutions sector, has recently announced an increment in its hold over ApoNow GmbH, amplifying its majority stake from 50.1% to a significant 80.0%. This strategic move not only consolidates The Platform Group AG's influence in the pharmaceutical and pharmacy platform sphere but also indicates a positive trajectory in ApoNow's operational success and growth potential.

ApoNow, with its base in Wetter (Ruhr), operates as a critical facilitator among pharmaceutical manufacturers and pharmacies across Germany, Austria, and Italy. The platform is instrumental in streamlining the order and delivery process for over 41,500 pharmacies, connecting them with more than 300 manufacturers. This system underscores ApoNow's unique position in facilitating direct communications and transactions in the pharmacy sector.

Dr. Dominik Benner, CEO of The Platform Group AG, expressed optimism about ApoNow's ongoing development and the strategic enhancement of their stake. Financed through The Platform Group AG's resources, the specifics of the deal remain undisclosed. The transaction, expected to close in April 2024, aligns with the group's broader acquisition strategy, targeting 3-8 companies in the B2B and B2C domains within the year.

The Platform Group AG continues to demonstrate agile growth and robust positioning across various sectors, backed by a strong financial outlook and a diversified operational base. With over 20 acquisitions since 2020, the group's strategic endeavors underscore a commitment to expanding its market presence and enhancing shareholder value.